君实生物:JS015单药在晚期实体瘤中首次人体研究已完成 联合治疗胃肠道肿瘤中II期临床研究在进行中

每日经济新闻
May 19

有投资者在投资者互动平台提问:请问公司JS015 DKK1单抗目前进度如何,什么时候可以公布II期数据?  君实生物(688180.SH)5月19日在投资者互动平台表示,JS015(DKK1单抗)单药在晚期实体瘤中的首次人体研究已经完成,联合治疗在胃肠道肿瘤中的II期临床研究正在进行中,相关临床数据请以公司公告或学术会议报告为准。(文章来源:每日经济新闻)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10